BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31916017)

  • 21. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
    Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes.
    Jaffrelot M; Farés N; Brunac AC; Laurenty AP; Danjoux M; Grand D; Icher S; Meilleroux J; Mery E; Buscail E; Maulat C; Toulas C; Vande Perre P; Chipoulet E; Bonnet D; Staub A; Guimbaud R; Selves J
    Mod Pathol; 2022 Mar; 35(3):427-437. PubMed ID: 34545179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors.
    Gambichler T; Finis C; Abu Rached N; Scheel CH; Becker JC; Lang K; Käfferlein HU; Brüning T; Abolmaali N; Susok L
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1241-1247. PubMed ID: 35419731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mismatch repair deficiency is rare in bone and soft tissue tumors.
    Lam SW; Kostine M; de Miranda NFCC; Schöffski P; Lee CJ; Morreau H; Bovée JVMG
    Histopathology; 2021 Oct; 79(4):509-520. PubMed ID: 33825202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.
    Clay MR; Allison KH; Folkins AK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mismatch Repair Deficiency in Adult Granulosa Cell Tumors: an Immunohistochemistry-based Preliminary Study.
    Gupta P; Kapatia G; Gupta N; Ballari N; Rai B; Suri V; Rajwanshi A
    Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):540-548. PubMed ID: 35960021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERCC1, MLH1, MSH2, MSH6, and βIII-tubulin: resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma.
    Ting S; Mairinger FD; Hager T; Welter S; Eberhardt WE; Wohlschlaeger J; Schmid KW; Christoph DC
    Clin Lung Cancer; 2013 Sep; 14(5):558-567.e3. PubMed ID: 23810210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis.
    Haraldsdottir S; Roth R; Pearlman R; Hampel H; Arnold CA; Frankel WL
    Fam Cancer; 2016 Apr; 15(2):253-60. PubMed ID: 26666765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Tissue Mismatch Repair Protein Deficiency between Early- and Advanced-Stage Endometrial Cancer.
    Chaowiwatkun K; Trongwongsa T; Rodpenpear N; Nutthachote P
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):345-351. PubMed ID: 36708586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prognostic Value of Deficient Mismatch Repair in Stage II-IVa Nasopharyngeal Carcinoma in the Era of IMRT.
    Chen FM; Zhang YX; Li XF; Gao JF; Ma H; Wang XL; Li Y; Li C; Zhang YN; Zhang YT; Kan HX; Li H; Zhang SG; Hao FR; Wang MC
    Sci Rep; 2020 Jun; 10(1):9690. PubMed ID: 32546739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland.
    Karpińska-Kaczmarczyk K; Lewandowska M; Ławniczak M; Białek A; Urasińska E
    Med Sci Monit; 2016 Aug; 22():2886-92. PubMed ID: 27527654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications.
    Doghri R; Houcine Y; Boujelbène N; Driss M; Charfi L; Abbes I; Mrad K; Sellami R
    Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):678-682. PubMed ID: 31567138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
    Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma.
    Mettman D; Haer E; Olyaee M; Rastogi A; Madan R; O'Neil M; Kelting S; Dennis K; Fan F
    Ann Diagn Pathol; 2020 Aug; 47():151552. PubMed ID: 32570025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High homogeneity of mismatch repair deficiency in advanced prostate cancer.
    Fraune C; Simon R; Höflmayer D; Möller K; Dum D; Büscheck F; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Hinsch A; Burandt E; Clauditz TS; Wilczak W; Sauter G; Steurer S
    Virchows Arch; 2020 May; 476(5):745-752. PubMed ID: 31811435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
    Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Amin T; Viol F; Fehrle W; Dum D; Höflmayer D; Burandt E; Clauditz TS; Perez D; Izbicki J; Wilczak W; Sauter G; Steurer S; Schrader J
    Endocr Pathol; 2020 Jun; 31(2):182-189. PubMed ID: 32144630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
    Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
    Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.